CRISPR system variant shows a novel DNA cleavage mechanism
Researchers have revealed new details about the CRISPR-Cas5-HNH/Cascade complex, a variant of the type I-E CRISPR-Cas system, ...
Citi raises VeriSign stock price target to $260 on robust 4Q results
Citi analyst Ygal Arounian increased the price target for VeriSign (NASDAQ:VRSN) stock to $260 from the previous $250, while maintaining a Buy rating on the shares. The company, currently valued at ...